The 5 Tech Trends Every Founder Must Act On Now

Most trend reports are noise. Forbes contributor Bernard Marr's five-trend framework for 2026 is different. Rather than padding a listicle with adjacent buzzwords, Marr narrows the field to AI agents, spatial computing, energy tech, biotech convergence, and quantum computing, and makes an explicit case that each one is already reshaping capital allocation, not just generating conference panel buzz. For founders currently raising or pivoting, this is the benchmark worth reading against. The piece has logged over 36,000 YouTube views since its September 2025 release, which signals genuine traction among a decision-making audience, not just casual tech browsers.

The timing matters. Published in late 2025 and now live against the reality of mid-2026, Marr's framework functions as a real-time scorecard. AI agents have moved from proof-of-concept to production faster than most enterprise roadmaps anticipated, with autonomous workflow automation now a standard agenda item in board-level strategy reviews. Spatial computing, once dismissed as a post-Vision Pro hangover, is quietly becoming the interface layer for industrial and surgical applications. The gap between what Marr predicted and what has already materialised is narrower than his critics expected. That credibility matters when founders are using frameworks like this to pitch trend alignment to investors.

The most underrated signal in the framework is the energy tech inclusion. Marr frames the growing compute demands of AI infrastructure as tech's defining resource constraint, and the data backs that up. AI training and inference workloads have driven data centre energy consumption to levels that are forcing hyperscalers to revisit nuclear, geothermal, and advanced grid storage at speed. Quantum computing sits at the opposite end of the maturity curve, but Marr's framing, that 2026 is the year businesses should be building quantum readiness rather than waiting for quantum advantage, is the right strategic posture. Companies that treat quantum as a 2030 problem are already behind on talent and vendor relationships.

The biotech convergence thread is where the framework gets most interesting for investors. Marr's position is that AI and biology are no longer adjacent fields but are compounding together, with drug discovery, diagnostics, and synthetic biology now running on the same foundational model infrastructure as enterprise software. That convergence creates genuine cross-sector opportunity for founders who can operate at the intersection. It also raises the stakes for investors who have kept life sciences and deep tech in separate mental buckets. The walls between those verticals are collapsing faster than most portfolio strategies have accounted for.

Over the next twelve months, the divergence between companies that treated these five trends as strategic priorities and those that treated them as background noise will become measurable in revenue and valuation multiples. AI agents will move from departmental experiments to core operating infrastructure, forcing every SaaS founder to redefine what their product actually does when automation handles the workflow layer. Energy tech investment will accelerate as regulatory pressure and compute demand create a rare alignment of government and private capital. Founders who used 2025 to build fluency in these shifts will spend 2026 executing. Everyone else will spend it catching up.